We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation. Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation.
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases...
U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24 Strong financial position with cash and cash equivalents totaling $269.1 million as of December 31, 2023 SAN...
Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate strategy IND-enabling toxicology studies of THB335 nearing completion;...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.31 | -2.66323024055 | 11.64 | 12.24 | 10.39 | 299233 | 11.27885388 | CS |
4 | 2.23 | 24.5054945055 | 9.1 | 12.42 | 8.365 | 229114 | 10.91778296 | CS |
12 | 2.56 | 29.1904218928 | 8.77 | 12.42 | 8.075 | 154232 | 10.26655246 | CS |
26 | 4.82 | 74.0399385561 | 6.51 | 12.42 | 5.765 | 153963 | 9.57300833 | CS |
52 | 7.09 | 167.216981132 | 4.24 | 12.42 | 4.06 | 131081 | 8.04349667 | CS |
156 | -9.17 | -44.7317073171 | 20.5 | 25 | 3.75 | 163097 | 8.15930314 | CS |
260 | -9.17 | -44.7317073171 | 20.5 | 25 | 3.75 | 163097 | 8.15930314 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions